|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||18.44 - 18.44|
|52-week range||18.44 - 18.44|
|Beta (5Y monthly)||0.65|
|PE ratio (TTM)||N/A|
|Earnings date||05 Aug 2021 - 09 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Some Aclaris Therapeutics, Inc. ( NASDAQ:ACRS ) shareholders are probably rather concerned to see the share price fall...
Aclaris Therapeutics (ACRS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Aclaris (ACRS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.